SINGAPORE (Aug 14): Tianjin Zhong Xin Pharmaceutical Group Corporation has recorded earnings of RMB 156.9 million ($30.8 million) or 0.20 RMB cents per share for the 2Q19 ended June, some 10% higher than earnings of RMB 142.2 million a year ago.
2Q19 revenue rose 19% to RMB 1.78 billion, compared to RMB 1.50 billion a year ago.
Marketing and distribution costs grew 12% to RMB 489.7 million during the quarter, from RMB 435.5 million a year ago.
